期刊文献+

以榄香烯乳为耐药调变剂联合化疗耐药胃癌临床观察 被引量:28

Clinical Observations of Gastric Cancer Patients Treated with Chemotherapy and Elemene as a MDR Mediator
下载PDF
导出
摘要 目的:观察榄香烯乳有无逆转晚期胃癌患者对化疗药物的耐药性。方法:共选择42例晚期胃癌患者,随机分为三组:1单纯化疗组;2单纯榄香烯乳治疗组;3榄香烯乳联合化疗组。结果:单纯榄香烯乳治疗组有效率为9%,单纯化疗组为0%,榄香烯乳联合化疗组为286%。结论:榄香烯乳联合化疗可提高肿瘤细胞对化疗药物的敏感性。 Objective:To judge whether there was any effect of elemene in reversing the MDR in patients with advanced gastric cancer.Methods:All patients enrolled in this study were divided into 3 groups.Group 1 was only treated with chemotherapy;Group 2 only with elemene;while Group 3 combined with elemene and chemotherapy.Results:There was no complete or partial response in Group 1;9% of partial response in Group 2;And 28 6% in Group 3.There were statistical differences among the 3 groups.( P <0 05; P <0 01)Conclusion:The elemene might change the MDR in gastric cancer patients who had not any response to the previous chemotherapy.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 1999年第3期215-216,共2页 Cancer Research on Prevention and Treatment
关键词 榄香烯乳 胃癌 药物疗法 联合化疗 抗药性 Gastric cancer MDR mediator Elemene
  • 相关文献

参考文献5

二级参考文献3

  • 1孙燕,实用肿瘤杂志,1990年,5卷,129页
  • 2孙燕,肿瘤化学治疗新进展,1987年
  • 3傅乃武,中药通报,1984年,2卷,35页

共引文献46

同被引文献405

引证文献28

二级引证文献258

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部